1307264-35-2

Upstream product

• 1307264-22-7 C₂₃H₃₂O₇ 
• 925545-39-7 6-O-benzyl-1,2,3-trideoxy-4,5:7,8-di-O-isopropylidene-D-altro-oct-1-enitol 

Downstream Products

• 1307264-26-1 C₁₇H₂₁NO₅ 
• 1307264-27-2 C₁₇H₂₃NO₅ 
• 1307264-28-3 (6S,7R)-6-chloro-7-benzyloxy-cocaine 
• 1307264-29-4 (7S)-hydroxy-cocaine 
• 172300-42-4 (7S)-chloro-cocaine 
• 1307264-30-7 (7S)-methanesulfonyloxy-cocaine 
• 1307264-31-8 (7S)-iodo-cocaine 
• 1307264-37-4 C₃₁H₂₉NO₈ 
• 1307264-23-8 C₂₀H₂₇NO₆ 
• 1307264-21-6 C₂₀H₂₇NO₆ 
• 1307264-25-0 C₁₇H₂₃NO₆ 
• 1307264-24-9 C₁₇H₂₃NO₆ 
• 50-36-2 Cocaine 

Relevant academic research and scientific papers

Facile and enantiospecific syntheses of (6 S,7 R)-6-chloro-7-BENZYLOXY-, (7 S)-halo-, and (7 S)-hydroxy-cocaine and natural (-)-cocaine from d -(-)-ribose

First syntheses of C6,7 and C7 enantiopure cocaine analogues were achieved from d-(-)-ribose via a trans-acetonide controlled endo-selective intramolecular nitrone-alkene cycloaddition (INAC) as the key step. This synthetic scheme allows practical preparation of cocaine analogues for bioevaluation as potential candidates for the treatment of cocaine addiction and as potential conjugates for immunotherapy.